Research Paper Volume 12, Issue 10 pp 9311—9327
Single nucleotide polymorphisms within the Wnt pathway predict the risk of bone metastasis in patients with non-small cell lung cancer
Figure 4. The relationship between serum tumor markers in patients with NSCLC bone metastases and different genotypes of CTNNB1: rs1880481. The serum tumor markers contained (A) carcinoembryonic antigen (CEA), (B) cytokeratin fragment 19 (CYFRA21-1), (C) neuron-specific enolase (NSE), and (D) squamous cell carcinoma (SCC) antigen.